The term macular degeneration quite rightly harbours a great deal of fear as it is commonly known that it can lead to blindness. Whilst this indeed can be the case, luckily medical science has advanced tremendously over the recent past whereby we now help preserve the vision of those afflicted with this terrible condition.
In order to achieve this, the name of the game is teamwork. The role of the patient is to recognise symptoms early and present to the ophthalmologist without delay. The cardinal symptoms of macular disease are distortion and seeing things smaller than the actually are: please do not take these symptoms lightly as they can represent problems in the macula, more specifically in the retired population, age related macular degeneration (AMD).
Broadly speaking, one can categorise AMD into two groups: dry and wet. Dry disease is generally slower in nature and recently there has been an explosion of research and development of newer treatments that can have significant impact in one´s life.
The wet type can be more devastating in terms of sight loss and treatment with protocols have existed for many years. It is worth noting that approximately 10% of ´dry´ disease can convert into ´wet´, hence the importance of being vigilant regarding new symptoms of distortion. Distortion should be monitored with an Amsler Grid, which can be provided by an ophthalmologist at a consultation.
Macular disease as a whole tends to cause visual morbidity and loss in the centre of the visual field, whilst preserving vision in the periphery. Sadly, what we do see frequently is coexisting disease in the form of macular disease (affecting the centre) and glaucoma, which of course causes loss of vision in the periphery. One can appreciate that both diseases together are even more devastating in tandem. The good thing is early detection and treatment can slow and stop progression.
Here in Clinica Guirao, we are fortunate to have specialists within these fields, to devise appropriate management plans and treatment options. We welcome January and February as both glaucoma and macular degeneration awareness months so that we have the opportunities to inform and educate the public as to the dangers of these devastating conditions and the importance of regular assessments with specialist in order to identify and treat in a timely manner.





